Cynapsus Therapeutics Company
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson–≤–Р–©s disease.
Total Funding:
$23.8M
Investor Type:
For Profit
Technology:
Biologics
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Founded Date:
2004
Industry:
PharmTech
Employee Number:
11-50
Funding Status:
M&A
Headquarters:
Canada
Investors Number:
3